N-acetylcysteine as an add-on to Directly Observed Therapy Short-I therapy in fresh pulmonary tuberculosis patients: A randomized, placebo-controlled, double-blinded study.

Perspect Clin Res · 2017 · PMC5543764 · PMID 28828308

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The early sputum negativity seen in the NAC supplemented patients (95.83%) at the end of 3 weeks is a highly significant finding compared to (58.33%) placebo add-on to DOTS Category I regimen.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.